Navigating the Tumor Microenvironment: The Role of Reactive Oxygen Species in Cancer Progression and Therapy

A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Cancer Biology and Oncology".

Deadline for manuscript submissions: closed (30 April 2025) | Viewed by 466

Special Issue Editor


E-Mail Website
Guest Editor
Department of Pathology and Microbiology, University of Nebraska Medical Center, Omaha, NE 68198, USA
Interests: oxidative stress and free radical biology; microbial infections; tumor immunology; cancer biology; pancreatic; tumor
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The tumor microenvironment (TME) plays a crucial role in defining the progression of different cancers. Reactive oxygen species (ROS) produced by tumor cells and tumor-infiltrated immune cells are essential in shaping the TME. The stromal components of the tumor can affect the TME and influence drug response in tumor cells. In multiple cancers, chemotherapy and radiotherapy have been shown to increase intracellular ROS, which can lead oxidative stress (OS)-induced apoptosis and cell death. Oxidative stress is defined as an imbalance between the production of ROS and their elimination by protective antioxidants. OS can cause DNA mutations and/or genomic instability. This leads to the initiation and progression of cancer. However, when discussing the role of OS in cancers, ROS act as a double‐edged sword. Although low levels of ROS can induce a proliferative effect and induce signaling pathways, high levels of ROS can cause damage to cancer tissues and cell death. Antioxidants can spare and protect normal tissues. However, existing data indicate that antioxidants may also protect tumor cells from oxidative damage induced by some chemotherapeutic agents. In this Special Issue, we will discuss recent findings relating oxidative stress and ROS to the TME in cancer and responses to chemo- and radiotherapy. In addition, we discuss how different studies may aid in identifying new targets for the development of drugs for cancer therapy.

Dr. Maher Y. Abdalla
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • tumor microenvironment
  • reactive oxygen species
  • oxidative stress
  • antioxidants
  • tumor-infiltrated immune cells

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 1879 KiB  
Review
Redox Balance in Cancer in the Context of Tumor Prevention and Treatment
by Paweł Sutkowy and Przemysław Czeleń
Biomedicines 2025, 13(5), 1149; https://doi.org/10.3390/biomedicines13051149 - 9 May 2025
Viewed by 296
Abstract
Malignant neoplasms constitute a substantial health concern for the human population, currently ranking as the second leading cause of mortality worldwide. In 2022, approximately 10 million deaths were attributable to cancer, and projections estimate that this number will rise to 35 million in [...] Read more.
Malignant neoplasms constitute a substantial health concern for the human population, currently ranking as the second leading cause of mortality worldwide. In 2022, approximately 10 million deaths were attributable to cancer, and projections estimate that this number will rise to 35 million in 2050. Consequently, the development of effective cancer treatments and prevention strategies remains a primary focus of medical research. In this context, the impacts on the redox balance are being considered. The objective of this study was to present the current knowledge on oxidation and reduction processes in cancer. This review discloses the intricate and multifaceted interplay of oxidoreductive systems during carcinogenesis, which engenders discordant findings in the domain of tumor prevention and treatment. This study also examines the controversies surrounding the use of antioxidants, including their impact on other therapeutic interventions. The review offers a comprehensive overview of the existing knowledge on the subject, concluding that personalized and precise anticancer therapies targeting the redox processes can serve as both effective diagnostic and therapeutic tools. Full article
Show Figures

Figure 1

Back to TopTop